Fibrilación atrial: nuevos conceptos
DOI:
https://doi.org/10.51481/amc.v46i2.141Palabras clave:
arritmia, cardioversión, anticoagulación, cardiopatía, automatismo, reentradaResumen
La fibrilación atrial (FA) es la disrritmia sostenida más común, con una prevalencia de 5% en pacientes mayores de 65 años, y es una importante causa de accidente vascular cerebral (AVC), alrededor del 5%, por año, de los pacientes que la padecen y no están anticoagulados, tendrán un episodio de AVC……….
Descargas
Citas
Ukani ZA, Ezekowitz MD. Tratamiento actual de la fibrilación auricu-lar. Clin Med NA 1995;5: 1119-1138.
Hohnloser SH, Kuck K, Lilienthal J. Rhythm or rate control in atrial fibrillation-pharmacological intervention in atrial fibrillation (PIAF): a randomised trial. Lancet 2000;356: 1789-94.
Klein AL, Grimm RA, Murray D, Apperson-Hansen C, Asinger RW, Black IW, et al. Use of transesophageal ecocardiography to guide car-dioversion in patients with atrial fibrillation. N Engl J Med 2001;344: 1411-20.
Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, et al. Amiodarone to prevent recurrence of atrial fibrillation. N Engl J Med 2000;342: 913-20.
Albers GW, James DE, Laupacis A, Manning WJ, Palle P, Singer DE. Antithrombotic therapy in atrial fibrillation. Chest 2001;119: 194s-206s.
Silverman DI, Manning WJ. Role of echocardiography in patients undergoing elective cardioversion of atrial fibrillation. Circulation 1998;98:479-486.
Markides V, Schilling RJ. Atrial Fibrillation: classification, pathophy-siology, mechanisms and drug treatment. Heart 2003;89: 939-943.
Blaauw Y, Van Gelder IC, Crijns HJGM. Treatment of atrial fibrilla-tion. Heart 2002;88:432-437.
Madrid AH, Bueno MG, Rebollo JMG, Marín I, Peña G, Bernal E, et al. Use of irbersartan to maintain sinus rhythm in patients with long-las-ting persistent atrial fibrillation: a prospective and randomized study. Circulation 2002;106:331-336.
Mittal S, Ayati S, Stein KM, Schawartzman D, Cavlovich D, Tchou PJ, et al. Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Cir-culation 2000;101:1282-1287.
Lönne rholm S, Blomström P, Nilsson L, Oxelbark S, Jideus L, Blomström-Lundqvist C. Effects of the maze operation on health-related quality of life in patients with atrial fibrillation. Circulation 2000;101:2607-2611.
Wyndham CRC. Atrial fibrillation: the most common arrhytmia. Tex Heart Inst J 2000;27:257-267.
Falk RH, Atrial fibrillation. N Engl J Med 2001;344:1067-78.
Arango JJ. Manual de electrocardiografía. Cap.19. Taquiarritmias. Cor-poración para investigaciones biológicas. Colombia. 1996, p:205-208.
Josephson ME, Zimetbaum P, Buxton AE, Marchlinsk FE. Harrison: principios de Medicina Interna. Cap. 231. Las taquiarritmias. Mc Graw Hill. México. 1999, p:1446-1447.
Robles EO, Algra A. Digoxin in the treatment of paroxysmal atrial fibri-llation. Lancet 1999;354:882-83.
Cooper JM, Katcher MS, Orlov MV. Implantable devices for the treat-ment of atrial fibrillation. N Engl J Med 2002;346:2062-2068.
Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats origu-nating in the pulmonary veins. N Engl J Med 1998;339:659-66.
Almendral J, Marín E, Medina O, Peinado R, Pérez L, Ruiz R, et al. Guía de práctica clínica de la sociedad española de cardiología de arrit-mias cardiacas. Rev Esp Cardiol 2002;54:307-67.
The atrial fribrillation follow-up investigation of rhythm manegement (AFFIRM) investigators. A comparision of rate control and rhythm con-trol in patientes with atrial fribrillation. N Engl J Med 2002;347:1835-33.
Berge E, Abdelnoor M, Nakstad PH, Sandset PM. Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fribrillation: a double-blind randomised study. Lancet 2000;355:1205-10.
Ozcan C, Jahangir A, Friedman PA, Patel PJ, Munger TM, Rea RF, et al. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrilla-tion. N Engl J Med 2001;344:1043-51.
Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001;344:501-9.
Allessie MA, Boyden PA, Camm AJ, Kléber AG, Lab MJ, Legato MJ, et al. Pathophysiology and prevention of atrial fibrillation. Circulation 2001;103:769-777.
Morady F. Radio-frequency ablation as treatment for cardiac arrhyth-mias. N Engl J Med 1999;340:534-44.
Feng TC, Tai CT, Hsieh MH, Lin WS, Yu WC, Ueng KC, et al. Initia-tion of atrial fibrillation by ectopic beats originating from superior vena cava: electrophysiological characteristics and results of radiofrequency ablation. Circulation 2001;102:67-74.
Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med 2001;345:1473-82.
Zipes DP. Braunwald: Tratado de Cardiología. Cap. 22. Arritmias espe-cíficas: diagnóstico y tratamiento. Mc Graw Hill. México, p:708-711.
Andreoli TE, Bennett JC, Carpenter CCJ, Plum F. Cecil: Compendio de Medicina Interna. Cap. 8. Arritmias. Mc Graw Hill. México. 1999, p:68-92.
Bigger JT. Cecil: Tratado de medicina interna. Cap. 35. Arritmias cardia-cas. Mc Graw Hill. México. 1999, p:266-277.
Iturralde P. Arritmias cardiacas. Cap. 7. Fibrilación y Flúter auricular. Mc Graw Hill. México. 1997, p:119-144.
Alpert MA. Medical cardio ve rsion of atrial fribrillation. Chest 2000;117:1530-31.
Sánchez K, Padilla J. Manual de enfoque práctico en cuidados intensi-vos. En diagnóstico y tratamiento de las taquiarritmias. Editorial de la Universidad de Costa Rica. Costa Rica 2000, p.86-92.
Giri S, White CM, Dunn AB, Felton K, Freeman-Bosco L, Reddy P, et al. Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the atrial fibrillation suppression trial (AFIST): a randomised placebo-controlled trial. Lancet 2001;357:830-836.
Curtis AB. New insights into the pharmacological management of atrial fibrillation. Medscape 2003.
Stambler BS, Wood MA, Ellebogen KA, et al. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flut-ter or fibrillation. Ibutilide repeat dose study investigators. Circulation 1996;94:1613-21.
Go AS, Hylek EM, Phillips KA, Borowsky LH, Henault LE, Chang Y, et al. Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation 2000;102:11-13.
Blackshear JL, Baker VS, Rubino F, Safford R, Lane C, Flipse T, et al. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: stroke prevention in atrial fibrillation III randomised clinical trial (SPAF III). Lancet 1996;348:633-38.
Lip GYH. Thro mboprophylaxis for atrial fibrillation. Lancet 1999;353:4-5.
Hammill SC, Hubmayr RD. The rapidly changing management of car-diac arrhythmias. Am J Respir Crit Care Med 2000;161:1070-73.
Sudlow M, Thomson R, Thwaites B, Rodgers H, Kenny RA. Prevalen-ce of atrial fibrillation and eligibility for anticoagulants in the commu-nity. Lancet 1998;352:1167-71.
Gornick Ch. Anticoagulant use in nonvalvular atrial fibrillation. Post-grad Med 2000;108:113-26.
O’Reilly RA. Katzung: Farmacología básica y clínica. Cap. 34. Fár-macos en los trastornos de la coagulación. Manual Moderno. México. 1999,p:640-643.
Ansell J, Hirsh J, Dalen J, Bussey H, Anderson D, Poller L, et al. Mana-ging oral anticoagulant therapy. Chest 2001;119:22s-38s.
Peters NS, Schilling RJ, Kanagaratnam PV, Markides V. Atrial fibri-llation: strategies to control, combat, and cure. Lancet 2002;359:593-603.
Scheinman MM, Morady F. Nonpharmacological approaches to atrial fibrillation. Circulation 2001;103:2120-2125.
Grant AO. Recent advances in the treatment of arrhythmias. Circ J;67:651-655.
Daoud EG, Dabir R, Archambeau M, Morady F, Strickberger A. Rando-mized, double-blind trial of simultaneous right and left atrial epicardial pacing for prevention of post-Open heart surgery atrial Fibrillation. Ciculation 2000;102:761-765.
Galloway AC, Anderson RU, Brossi EA, ESsencer FC, Colvin SB. Schwartz: principios de cirugía. Cap. 18. Cardiopatías adquiridas. Mc Graw Hill. México, p:964-965.
Jessurun ER, van Hemel NM, Defauw J, Stofmeel M, Kelder JC, de la Rivière AB, et al. Results of maze surgery for lone paroxysmal atrial fibrillation. Circulation;101:1559-1567.
Winlaw DS, Farnsworth AE, Macdonald PS, Mundy JA, Spratt PM. Left atrial reduction: the forgotten Batista. Lancet 1998;351:879-80.
Johnson F. Atrial fibrillation after coronary artery bypass grafting. The Internet Journal of Cardiology 2002;1:1-3.
Wurderman RL, Mooss AN, Mohiuddin SM, Lenz TL. Amiodarone vs sotalol as prophylaxis against atrial fibrillation/flutter after heart sur-gery: a meta-analysis. Chest 2002;121:1203-1209.
Stamou SC, Hill PC, Sample GA, Snider E, Pfister AJ, Lowery RC, et al. Prevention of atrial fibrillation after cardiac surgery: the significance of postoperative oral amiodarone. Chest 2001;120:1936-1941.
Crystal E, Connolly SJ, Sleik K, Ginger TJ, Yusuf S. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis. Circulation 2002;106:75-80
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2008 Acta Médica Costarricense

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)